{"id":9194,"date":"2020-08-19T11:18:23","date_gmt":"2020-08-19T18:18:23","guid":{"rendered":"https:\/\/depts.washington.edu\/pandemicalliance\/?p=9194"},"modified":"2021-04-15T11:19:00","modified_gmt":"2021-04-15T18:19:00","slug":"allergic-disorders-and-susceptibility-to-and-severity-of-covid-19-a-nationwide-cohort-study","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/pandemicalliance\/2020\/08\/19\/allergic-disorders-and-susceptibility-to-and-severity-of-covid-19-a-nationwide-cohort-study\/","title":{"rendered":"Allergic Disorders and Susceptibility to and Severity of COVID-19: A Nationwide Cohort Study"},"content":{"rendered":"<ul>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"34\" data-aria-posinset=\"2019\" data-aria-level=\"1\"><span data-contrast=\"auto\">In a propensity-score-matched nationwide cohort study<\/span><span data-contrast=\"auto\">\u00a0(n=219,959)<\/span><span data-contrast=\"auto\">\u00a0<\/span><span data-contrast=\"auto\">of individuals tested for SARS-CoV-2\u00a0<\/span><span data-contrast=\"auto\">in South Korea,\u00a0<\/span><span data-contrast=\"auto\">patients with\u00a0<\/span><span data-contrast=\"auto\">allergic rhinitis and asthma<\/span><span data-contrast=\"auto\">\u00a0were more likely to have a positive SARS-CoV-2 test and to have severe COVID-19 outcomes if infected, compared to individuals without these conditions. The greatest increased risk was among those with non-allergic asthma (for positivity,\u00a0<\/span><span data-contrast=\"auto\">aOR<\/span><span data-contrast=\"auto\">=<\/span><span data-contrast=\"auto\">1.3<\/span><span data-contrast=\"auto\">,\u00a0<\/span><span data-contrast=\"auto\">95%CI<\/span><span data-contrast=\"auto\">\u00a0<\/span><span data-contrast=\"auto\">1.<\/span><span data-contrast=\"auto\">1<\/span><span data-contrast=\"auto\">\u20131.7<\/span><span data-contrast=\"auto\">; for severe disease,\u00a0<\/span><span data-contrast=\"auto\">aOR<\/span><span data-contrast=\"auto\">=4.<\/span><span data-contrast=\"auto\">1<\/span><span data-contrast=\"auto\">, 95%<\/span><span data-contrast=\"auto\">CI 1.<\/span><span data-contrast=\"auto\">7<\/span><span data-contrast=\"auto\">\u201310.5<\/span><span data-contrast=\"auto\">)<\/span><span data-contrast=\"auto\">.<\/span><span data-ccp-props=\"{&quot;134233279&quot;:true}\">\u00a0<\/span><\/li>\n<\/ul>\n<p><i><span data-contrast=\"none\">Yang et al. (Aug 7, 2020). Allergic Disorders and Susceptibility to and Severity of COVID-19: A Nationwide Cohort Study. Journal of Allergy and Clinical Immunology.\u00a0<\/span><\/i><a href=\"https:\/\/doi.org\/10.1016\/j.jaci.2020.08.008\"><span data-contrast=\"none\">https:\/\/doi.org\/10.1016\/j.jaci.2020.08.008<\/span><\/a><span data-ccp-props=\"{&quot;134233279&quot;:true,&quot;335559685&quot;:720}\">\u00a0<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>In a propensity-score-matched nationwide cohort study\u00a0(n=219,959)\u00a0of individuals tested for SARS-CoV-2\u00a0in South Korea,\u00a0patients with\u00a0allergic rhinitis and asthma\u00a0were more likely to have a positive SARS-CoV-2 test and to have severe COVID-19 outcomes if infected, compared to individuals without these conditions. The greatest increased risk was among those with non-allergic asthma (for positivity,\u00a0aOR=1.3,\u00a095%CI\u00a01.1\u20131.7; for severe disease,\u00a0aOR=4.1, 95%CI 1.7\u201310.5).\u00a0&#8230;<\/p>\n<div><a class=\"more\" href=\"https:\/\/depts.washington.edu\/pandemicalliance\/2020\/08\/19\/allergic-disorders-and-susceptibility-to-and-severity-of-covid-19-a-nationwide-cohort-study\/\">Read more<\/a><\/div>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[6],"tags":[],"topic":[20],"class_list":["post-9194","post","type-post","status-publish","format-standard","hentry","category-article-summary","topic-clinical-characteristics-and-health-care-setting"],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/9194","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/comments?post=9194"}],"version-history":[{"count":1,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/9194\/revisions"}],"predecessor-version":[{"id":9195,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/9194\/revisions\/9195"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/media?parent=9194"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/categories?post=9194"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/tags?post=9194"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/topic?post=9194"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}